**Dhansa Labs Limited** (formerly known as **Ambey Laboratories Limited**) is a prominent Indian manufacturer specializing in the agrochemical and home hygiene sectors. With an operational legacy spanning over **40 years**, the company has established itself as the **third-largest manufacturer of 2,4-D** in India. Following its successful listing on the **NSE Emerge Platform** in **July 2024**, the company is currently undergoing a strategic transformation, rebranding its corporate identity and diversifying into renewable energy and biofuels. --- ### **Manufacturing Infrastructure and Vertical Integration** The company’s competitive edge is rooted in its high degree of **backward integration** into base chemicals, which ensures stringent quality control and cost efficiency. * **Primary Facility:** Operates a **5-acre (20,000 sq. m.)** production site in **Behror, Rajasthan**. * **Environmental Management:** The facility includes a dedicated Effluent Treatment Plant (ETP) with a capacity of **125,000 liters per day**. * **Production Capacities:** | Product / Category | Annual Production Capacity | | :--- | :--- | | **2,4-D** (Herbicide) | **6,000 MT** | | **Pretilachlor** | **1,000 MT** | | **Metribuzin** | **100 MT** | | **Other Agrochemicals & Intermediates** | **10,000 MT** | --- ### **Product Portfolio: Technical Grades and Formulations** Dhansa Labs holds over **200 product and combination registrations**. Its portfolio spans Technical Grade pesticides (high-purity active ingredients) and specialized Formulations (ready-to-use delivery systems). #### **1. Herbicides (Weed Control)** * **2,4-D Series:** Includes **2,4-D Acid 98% TC**, **Sodium 95% SP**, **Amine** (various concentrations), **Ethyl Hexyl Ester 96% TC**, and **Ethyl Ester 96% TC**. * **Pretilachlor:** Available in **95% TC**, **50% EC**, and **37% EW**. * **Metribuzin:** Offered as **97% TC** and **70% WS**. * **Clodinofob Tech:** High-purity technical grade for grass weed control. #### **2. Insecticides (Pest Control)** * **Chlorpyriphos:** Broad-spectrum insecticide in **97% TC**, **20% EC**, and **50% EC**. * **Thiamethoxam:** Systemic insecticide in **96% TC**, **25% WG**, and **75% SG**. * **Lambda Cyhalothrine Tech:** Synthetic pyrethroid for diverse crop applications. #### **3. Fungicides (Disease Control)** * **Hexaconazole:** Systemic fungicide available in **92% TC**, **5% SC**, **5% EC**, and **10% EC**. --- ### **Strategic Rebranding and Green Energy Diversification** Effective **March 6, 2026**, the company rebranded to **Dhansa Labs Limited** to align with a broader vision beyond traditional agrochemicals. This transition includes a shift to a holding company structure with two key subsidiaries: * **Dhansa Green Energy Private Limited:** Acquired as a **100% subsidiary** on **August 14, 2025**. In **March 2026**, it entered land acquisition agreements for large-scale renewable energy projects. * **Dhansa Biofuels Power Private Limited:** Incorporated in **December 2025** to explore opportunities in the biofuels and power generation segments. --- ### **Financial Performance and Capital Structure** The company has utilized its public listing to deleverage its balance sheet and fund expansion. * **Revenue Growth:** Total income rose from **₹10,758.71 lakhs (FY23)** to **₹12,205.67 lakhs (FY24)**. * **Profitability:** Reported a Net Profit of **₹772.17 lakhs** for **FY24**, though recent periods have seen **margin compression** and a decline in net profit despite higher turnover. * **IPO and Equity:** Raised **₹44.68 crore** via an IPO of **62,58,000 shares** at **₹68 per share** (including a **₹58 premium**). * **Convertible Warrants:** Allotted **1,08,69,565 warrants** at **₹46** each. As of April 2026, **869,565** have been converted, with **10,000,000** outstanding. * **Debt Management:** Successfully pre-paid and redeemed **₹13.10 crore** in **Non-Convertible Debentures (NCDs)** in July 2025, significantly improving the **debt-to-equity ratio**. * **Promoter Holding:** Following an inter-se transfer of **1,74,37,420 shares** via gift in December 2025, the promoter group (led by Sarina Gupta) maintains a **68.49%** stake. --- ### **Market Strategy and Growth Catalysts** * **China+1 Strategy:** Positioning as a reliable alternative supplier to capitalize on the global shift away from Chinese chemical dependency. * **Export Expansion:** While currently domestic-heavy, the company is targeting the sale of **intermediates** in global markets. Foreign exchange earnings stood at **₹324.04 lakhs** in **FY25**. * **Enhanced Financial Limits:** Shareholders have approved borrowing and investment limits of up to **₹500 Crores** each under Sections 180 and 186 to facilitate aggressive scaling. * **Leadership:** Appointed **Mr. Archit Gupta** as **CEO** in **January 2025** to oversee the transition into new energy verticals and international markets. --- ### **Risk Factors and Operational Challenges** Investors should note the following headwinds: * **Agricultural Volatility:** High dependency on **monsoon patterns** creates seasonal demand fluctuations and inventory risks. * **Cash Flow Constraints:** The company has reported **significantly negative operating cash flows**, largely due to **delayed payments** from domestic customers and extended credit cycles. * **Regulatory Compliance:** As a new listed entity, the company faced a **₹2,18,300 fine** from the **NSE** for a **37-day delay** in filing FY24 results. Management is currently strengthening internal controls to address these "misunderstandings" of SME listing timelines. * **Supply Chain:** Reliance on raw material **imports from China** exposes the company to geopolitical risks and price volatility. * **Related Party Transactions:** The company utilizes a high volume of related-party transactions for supply chain management, with approved limits reaching **₹250 crore annually** for FY27 and FY28.